“This is a study of hope and optimism,” said Michael Alosco, a co-senior author of the latest paper and co-director of clinical research at the BU CTE Center. “It’s a study that really brings us closer to being able to diagnose during life, and this is what we’ve been working on for so many years now.”The findings are still preliminary, and no approved blood test for CTE exists. But the results mark a long-awaited step toward better understanding the condition, which is likely caused by repeated head injuries, including concussions and smaller impacts. Since CTE can only be definitively diagnosed after death by analyzing brain tissue, its true impact among living people remains unclear. That has made it challenging to develop treatments and prevention strategies.The threat that CTE poses to football players has recently come into sharper focus. A study published in October estimated that nearly three-quarters of all NFL players who died during a recent 15-year period had CTE. Athletes who play other contact sports, including hockey, rugby, and soccer, may be at risk as well. The disease has also been found in the brains of people in the military.Symptoms most often include cognitive impairment and dementia, as well as behavior and mood changes, which can be severe. Not every player with CTE will develop symptoms, particularly in the early stages of the disease.Photos provided by Boston University show sections from a normal brain, top, and from the brain of former University of Texas football player Greg Ploetz in stage IV of chronic traumatic encephalopathy.Ann McKee, MDThe new research examined 21 football players, including former professional, collegiate, and high school athletes, who gave blood samples while they were alive and donated their brains after death. Of the players studied, 18 had confirmed CTE and most were diagnosed with advanced disease.Using the last blood samples collected before the players died, researchers looked for a protein in the blood that could be a marker of tau tangles in the brain that are found in both CTE and Alzheimer’s patients, Alosco said. The tangles form inside neurons and can damage and kill them.The study found that athletes with more advanced disease had higher concentrations of the protein than those at early stages and people who did not have CTE.“What was really quite striking was just the difference,” Alosco said. “The high-stage CTE concentrations were just so much higher than anyone else, and that really stood out.”BU researchers co-led the study with colleagues at Banner Health, a hospital system in Arizona.The highest levels of the protein were found in people who had both CTE and Alzheimer’s. But researchers also looked at another protein associated with Alzheimer’s and found that it was not linked to CTE. Those combined findings suggest that both biomarkers could be used to detect CTE and differentiate it from Alzheimer’s, a disease that is similar to the head trauma condition, Alosco said. But he and other experts emphasized that the research is still in its “discovery phase.” The protein that was identified in the study is exciting for the field, said Dr. Ramon Diaz-Arrastia, a neurology professor at the University of Pennsylvania Perelman School of Medicine, who was not involved in the research. But he said the study’s sample size is small and the analysis leaves some critical questions unanswered.“It’s really just a hint,” Diaz-Arrastia said. “The sample size was way too small for us to make any guesses and any estimates as to what the diagnostic thresholds and things like that are.”Derek Monroe, an assistant professor of exercise and sport science at UNC Chapel Hill, said the study’s participants also aren’t representative of the broader population or even all football players. The analysis also included very few people with early stage CTE or no disease.“Before we know how this test performs, it must be studied in a broader group of people: those with and without a history of head impacts, with and without symptoms, followed over time,” said Monroe, who was not involved in the study.He and other experts noted that diagnosing CTE in the future will likely require more than one test, including brain imaging.“Ultimately, I do not think any single marker will solve this,” Monroe said. “The more realistic path is a combination of tools.”While the paper’s authors acknowledged its limited sample size, they highlighted a recent study from scientists at Washington University in St. Louis, who used a different approach and found that a related protein was higher in people with advanced CTE.“It’s very encouraging that two independent groups with two independent methods came to the same conclusion,” said Chihiro Sato, an assistant professor of neurology at Washington University in St. Louis and co-corresponding and senior author of the other study, also published in JAMA. Alosco said researchers are well-positioned to continue studying the latest finding. More people, he said, are participating in studies and donating their brains.“In a not so distant future, we’ll be able to do a larger one of these studies to validate it in a bigger sample,” he said. “If the findings hold up with future studies, this is really going to change the landscape.”Richard McElroy’s family said they wish the former collegiate athlete, who was one of the players included in the BU study, could have been diagnosed sooner.Janice McElroy, right, lost her husband to complications from CTE. She is pictured with her daughters, Michelle McElroy and Kristina McElroy.Lane Turner/Globe StaffRichard McElroy is seen in an undated picture.Janice McElroyJanice Howard McElroy said her husband’s behavior started to change in his early 50s. Richard McElroy, who seldom got mad, began having sudden angry outbursts and drinking heavily. At first, his wife thought he was going through a midlife crisis.“I didn’t know what was going on,” she said. “He had the most generous, loving heart.”Richard McElroy, who played football for four years at Mississippi State University, received care from CTE experts at BU. When he died in January at the age of 74, one of the first things his family did was start arranging for his brain to be donated. Doing so allowed McElroy, who was ultimately diagnosed with stage 4 CTE, to be included in the study.“I still obviously wish it could have helped him, but it still makes us feel amazing that this can be his legacy,” said his daughter Kristina McElroy, who spoke through tears. “He’s helping other people.”Allyson Chiu can be reached at allyson.chiu@globe.com. Follow her on X @_allysonchiu.